Peterson & Associates, P.C.


Avandia Recall

Categorized as Avandia, Dangerous Drugs

Avandia Recall: In Sept. 2010, the U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications. These new restrictions are in response to data that suggest an elevated risk of cardiovascular events,… Continue reading Avandia Recall